Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway

Jun 12, 2019Journal of ethnopharmacology

Liuwei Dihuang Pills may improve insulin sensitivity and ease polycystic ovary syndrome through the PI3K/Akt signaling pathway

AI simplified

Abstract

LWDH Pills (3.6 g kg·day) significantly reversed the phosphorylation alterations in PCOS-IR rats.

  • Phosphorylation of IRS-1 was increased, while PI3Kp85α, Akt, and FoxO1a showed reduced phosphorylation in PCOS-IR rats treated with LWDH Pills.
  • LWDH Pills led to higher mRNA levels of follicle-stimulating hormone receptor (FSHR) and Cyp19a1 in ovarian tissue.
  • Insulin resistance index improved towards normal levels following treatment with LWDH Pills.
  • Serum levels of follicle-stimulating hormone (FSH), estradiol, and progesterone increased, while luteinizing hormone (LH) and testosterone decreased.
  • Ovarian polycystic changes were alleviated, and the number of atretic follicles was reduced in treated rats.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free